Introduction
============

The application of ultrasound has greatly improved disease diagnosis and therapeutics in clinical practice. High-intensity focused ultrasound (HIFU) is an important method that causes a large temperature increase at the focal region, causing thermal ablation of tissue ([@B8]). HIFU is clinically employed for managing prostate cancer, hepatocellular carcinoma, uterine leiomyomas, and breast tumors ([@B6]). Although ablation itself has large effects, the higher energy is associated with the risk of adverse effects like skin burns and the possibility of energy absorption in the muscles and bones in the body ([@B6]).

Sonodynamic therapy (SDT) is a combination treatment of ultrasound irradiation and sonosensitizer administration that shows potential as a minimally invasive treatment for cancer ([@B17]). The sonosensitizer originated from the photosensitizer used for photodynamic therapy and displayed similar functions when combined with ultrasound instead of light ([@B30]; [@B27]). Several sonosensitizers have been reported, including the porphyrin complex, rose Bengal, titanium oxide, gold nanoparticles, and anticancer drugs like anthracyclines ([@B7]).

Although the mechanism of SDT is unclear, it is probably based on the activation of a sonosensitizer via acoustic cavitation and generation of reactive oxygen species (ROS) ([@B25]). In photodynamic therapy, the trigger for singlet oxygen generation is the light-based excitation of the photo-sensitizer. In contrast, SDT is thought to be more complex because of the non-direct reaction between the sonosensitizer and ultrasound. Some intermediate steps are related to acoustic cavitation between the initiation of ultrasound irradiation and final ROS generation. Acoustic cavitation involves gas bubbles in the medium generated via ultrasound irradiation. Inertial cavitation refers to the rapid growth and collapse of bubbles, and stable cavitation refers to the sustained oscillatory motion of bubbles ([@B22]). A previous study suggested two major mechanisms of ROS generation via acoustic cavitation, referred to as "sono-luminescence" and "pyrolysis" ([@B21]; [@B16]).

Several ROS are reportedly involved in SDT. Hydroxyl radicals are well-known ultrasound-related ROS ([@B21]). The superoxide anion is generated from doxorubicin, a widely used anticancer agent ([@B34]). Singlet oxygen is generated via SDT and photodynamic therapy ([@B4]).

Numerous challenges exist regarding nanoparticle preparation via sonosensitizers ([@B26]). Some sono-sensitizers are highly hydrophobic and show a disadvantageous distribution in the body. To overcome these limitations, an approach for forming nanoparticles, which are useful as drug delivery systems and include liposomes, polymers, and poly(lactic-co-glycolic acid), were reported including microbubble encapsulation ([@B20]; [@B32]; [@B9]; [@B31]). In addition to improving the distribution and sono-chemical activity, the existence of a particle in a liquid promotes the formation of a cavitation bubble because of its surface roughness ([@B26]). As another related technology, liposome preparations that release temperature-sensitive drugs following HIFU irradiation are being examined ([@B2]).

NC-6300 is an EPI-conjugated polyethylene glycol polyaspartate block copolymer. The conjugates form a micellar structure in aqueous media and exhibit the unique feature of pH-dependent drug release. Approximately 80% of EPI was found to be released within 1 h at pH 3 ([@B11]). This drug delivery system carrier has been confirmed to be safe based on the results of a phase 1 clinical trial ([@B23]).

Trigger-pulsed HIFU (TP-HIFU) is a programmed sequence consisting of two ultrasound waves. One is a high-intensity short duration pulse and the other is moderate-intensity long sustaining wave ([@B33]; [@B13]). TP-HIFU irradiation accelerates the generation of microbubble clouds and thermal coagulation ([@B29]).

We found that the combinatory use of NC-6300 and TP-HIFU irradiation was much more effective than each single therapy ([@B19]). We also conducted clinical safety tests for TP-HIFU and NC-6300 in pet dogs and confirmed the superior safety of this method.

Despite this progress in practical application, the mechanism of the combination effect and functional significance of the drug-polymer conjugate is unclear. In this study, we examined the effect of the combination of TP-HIFU and NC-6300 from the perspective of ROS generation and changes in drug characteristics.

Materials and Methods {#s1}
=====================

Reagents
--------

NC-6300 was obtained from NanoCarrier Co., Ltd. (with material transfer agreement) and diluted in Dulbecco's phosphate-buffered saline (DPBS) to prepare a stock solution (EPI concentration of 2 mM). EPI, distilled water, superoxide dismutase, RPMI 1640 medium, and accutase were from Nacalai Tesque (Kyoto, Japan). DPBS, iron(II) FeSO~4~, H~2~O~2~, xanthine, and xanthine oxidase were from Fujifilm Wako Pure Chemical (Osaka, Japan). Fetal bovine serum was from Gibco (Grand Island, NY, United States). Penicillin-streptomycin solution was from Sigma (St. Louis, MO, United States). Hydroxy phenyl fluorescein (HPF) was from Goryo Chemical (Sapporo, Japan), and Cell Counting Kit-8 (CCK-8) and WST-1 were from Dojindo Laboratories (Kumamoto, Japan). The Annexin V fluorescein isothiocyanate (FITC)-propidium iodide (PI) kit was from Medical and Biological Laboratories (Nagoya, Japan).

Cell Lines
----------

Human pancreas adenocarcinoma (BxPC-3) cells were obtained from the American Type Culture Collection (Manassas, VA, United States) and human peripheral blood promyeloblast (HL-60) cells were from the Japanese Collection of Research Bioresources Cell Bank. The cells were cultured in RPMI-1640 medium containing 10% fetal bovine serum and penicillin-streptomycin at 37°C and 5% CO~2~ in an incubator.

HIFU Irradiation
----------------

The *in vitro* HIFU system was constructed as shown in [Figure 1](#F1){ref-type="fig"}. The transducer was designed using a lead zirconate titanate ceramic element (resonant frequency 1.09 MHz, focus distance from transducer 75 mm) ([@B1]; [@B33]; [@B19]). The input signal was amplified with an amplifier (A300, Electronics and Innovation, Rochester, NY, United States) through the transducer, followed by the generation of the sequence by the function generator (WF1974, NF Corporation, Yokohama, Japan). The HIFU conditions (trigger sequence and duration of irradiation) were controlled with original software. The ultrasound intensity (spatial peak temporal average intensity; I~SPTA~, W/cm^2^) was measured using a needle-type hydrophone (HPM05, Precision Acoustics, Dorset, United Kingdom). TP-HIFU is a programmed wave mixture of a short-duration high-intensity triggering pulse (2000 W/cm^2^, 0.02 ms) followed by a heating wave (10--1000 W/cm^2^). N-HIFU was single heating wave irradiation (100 W/cm^2^) without the triggering pulse. The output energy of TP-HIFU at an ultrasound intensity of 100 W/cm^2^ was 10 W.

![**(A)** Schematic of the experimental setup. HIFU condition (trigger sequence and duration of irradiation) was controlled using original software. The signal generated from the function generator was amplified and then output to the transducer. **(B)** Sequence of TP-HIFU. High-intensity triggering pulse and heating wave were irradiated repeatedly. **(C)** Structure of NC-6300.](fphar-10-00546-g001){#F1}

All irradiation experiments were conducted in a water bath, which was filled with degassed circulating water (DEGASi High Flow, Biotec, Onsala, Sweden). The water temperature and dissolved oxygen concentration were maintained at 25 ± 2°C and \<3 mg/mL, respectively ([Figure 1](#F1){ref-type="fig"}).

The sample container for HIFU irradiation was changed as was necessary. Because plastic containers are easily deformed by high temperatures and long-duration irradiation, glass test tubes were used. For short-duration irradiation, 48- and 96-well plates were used to process multiple samples in one experiment.

Experiment on Degradation Stability and Release of EPI
------------------------------------------------------

The drug was dissolved in DPBS and irradiated with HIFU. Next, the drug concentration was measured using high-performance liquid chromatography as previously described for NC-6300 ([@B11]), with some modifications required for the laboratory conditions.

Cytotoxicity Test
-----------------

BxPC-3 cells were treated with accutase and detached from the plate at 37°C for 15 min. The detached cells were collected using centrifugation and diluted to 1 × 10^5^ cells/mL. An aliquot of the sample (0.34 mL) was added to each well of the 96-well plate. The HIFU irradiation group was placed in the water bath and HIFU irradiation was performed. During the experiment, the temperature of the water bath was maintained at 25 ± 2°C. HIFU-irradiated samples were dispensed at 0.1 mL into a 96-well microplate and cultured for the specified duration at 37°C and 5% CO~2~ in an incubator. After cell culture, 10 μL of CCK-8 was added and incubated for an additional 4 h at 37°C. The cell number was measured using a microplate reader (Infinite M1000 PRO, Tecan, Männedorf, Switzerland) at a wavelength of 438 nm. Cell viability was calculated using untreated cells as a control.

Hydroxyl Radical Detection Assay
--------------------------------

To detect hydroxyl radicals, fluorescence was measured using HPF. HPF was added to the sample solution at a final concentration of 0.025 mM. The sample solution was irradiated with HIFU after dispersion into a 48-well microplate (1.3 mL). The sample was dispensed into a 96-well plate for fluorescence intensity measurement. The fluorescence of the decomposed substance (HPF to fluorescein, ex. 490 nm, em. 515 nm) was measured in a microplate-reader (Infinite M1000 PRO). Three samples were included in each group, and the average value and standard deviation of the fluorescence changes were calculated.

Super Oxide Detection Assay
---------------------------

To measure superoxide anions, the WST-1 method was used ([@B28]). WST-1 was added to DPBS at a final concentration of 0.2 mM, and then NC-6300 or EPI was added to the 48-well microplate (1.3 mL) and TP-HIFU irradiation was performed (100 W/cm^2^, 0.5--3 min) at 25°C. The absorbance at a wavelength of 438 nm was measured using a UV-VIS-near infrared spectrophotometer (V-670DS, JASCO, Tokyo, Japan). Three samples were evaluated for each group, and the average value and standard deviation of absorbance changes were calculated before and after HIFU irradiation.

Flow Cytometer Analysis
-----------------------

The cellular accumulation of annexin V-FITC and PI was monitored using flow cytometry to detect changes in the membrane structure caused by ROS. HL-60 cells were cultured in RPMI-1640 medium containing 10% fetal bovine serum and penicillin-streptomycin, and diluted to 1 × 10^5^ cells/mL, and hydroxyl radicals or superoxide anions were generated by the Fenton reaction or xanthine/xanthine oxidase reaction. In the Fenton reaction, H~2~O~2~ solution and FeSO~4~ solution were added to a final concentration of 0.005--0.02 mM. In the xanthine/xanthine oxidase reaction, xanthine and xanthine oxidase were added to final concentrations of 0.005--0.02 mM and 40 mU/mL, respectively. The reaction was carried out at 37°C and 5% CO~2~ in an incubator. After incubation for 6 h, annexin-FITC and PI were added according to the manufacturer's instructions and the luminescence of FITC and PI was monitored with a flow cytometer (LSR Fortessa X-20, BD Biosciences, Franklin Lakes, NJ, United States) and analyzed using FlowJo v10 software (FlowJo LLC, Ashland, OR, United States).

Statistical analysis was carried out by using JMP software ver. 13.0.0 (SAS Institute, Cary, NC, United States).

Results
=======

We evaluated the effect of TP-HIFU irradiation and compared the amounts of hydroxyl radicals generated by N-HIFU and TP-HIFU. TP-HIFU generated more hydroxyl radicals even with short-duration irradiation compared to N-HIFU. Hydroxyl radical levels also increased as the HIFU intensity increased.

The cytoreductive effect of TP-HIFU was examined using BxPC-3 cells. The cells were irradiated with TP-HIFU or N-HIFU after detachment using accutase treatment. After 48 h of incubation, the survival of adherent cells significantly differed between the TP-HIFU and N-HIFU treatment groups.

Based on these results, TP-HIFU is a useful method for generating cavitation and cell killing effects after short-duration irradiation ([Figure 2](#F2){ref-type="fig"}).

![**(A)** Hydroxyl radical measurement by HPF method. In the Fenton reaction sample, H~2~O~2~ solution and FeSO~4~ solution were both added to HPF solution to final concentration of 5, 10, and 20 μM, respectively. The fluorescence intensity of the fluorescein released from HPF by hydroxyl radicals was measured with a microplate reader (ex./em. = 490/515 nm). HIFU irradiation groups were collected for five or more irradiation samples and the results are presented as the mean ± standard deviation. ^∗^*P* \< 0.05 non-parametric comparison for each pair by Wilcoxon test. **(B)** Cell viability assay of BxPC-3 cell line. Suspension of detached BxPC-3 cells were dispensed into a 96-well microplate for HIFU irradiation. Viable-cell counting was carried out by CCK-8 method. Each group was collected for 20 or more irradiation samples and the results are presented as the mean ± standard deviation. ^∗^*P* \< 0.05, ^∗∗^*P* \< 0.01, non-parametric comparison for each pair by Wilcoxon test.](fphar-10-00546-g002){#F2}

To confirm the stability of EPI against TP-HIFU, the change in the concentration of EPI upon TP-HIFU irradiation was measured. EPI showed slight decrease in concentration by TP-HIFU irradiation. However, EPI degradation was suppressed when NC-6300 was irradiated.

Because hydroxyl radicals may be related to EPI degradation upon HIFU irradiation, we examined the change in the concentration of EPI by hydroxyl radical addition using the Fenton reaction. The Fenton reaction is a source of hydroxyl radicals produced by the mixing of iron ion and H~2~O~2~. The EPI concentration was decreased by the generation of hydroxyl radicals. However, NC-6300 was relatively stable after the generation of hydroxyl radicals ([Figure 3](#F3){ref-type="fig"}).

![**(A)** EPI degradation test by TP-HIFU irradiation. The sample solution containing NC-6300 or EPI (0.1 mg/mL EPI concentration) was irradiated 10 min by TP-HIFU in test tube made of glass. Residual amount of EPI was calculated with non-irradiated sample set to 100%. The irradiation groups were collected as three samples and presented as the mean ± standard deviation. **(B)** EPI degradation test by Fenton reaction. The sample solution containing NC-6300 or EPI (0.01 mM EPI concentration) was treated with Fenton reaction in test tube. The residual amount of EPI was measured by HPLC (*n* = 2--3) and presented as the mean ± standard deviation. ^∗^*P* \< 0.05, ^∗∗^*P* \< 0.01, comparison for each pair by Tukey--Kramer test.](fphar-10-00546-g003){#F3}

To investigate the potency of NC-6300 as a sonosensitizer, we examined the detection of superoxide anion after HIFU irradiation. Because we could not detect superoxide anion using the electron spin resonance method, we used the spectroscopic method as previously reported ([@B28]).

We measured the amount of superoxide anion generated by TP-HIFU irradiation using a UV-VIS-near infrared spectrophotometer. As a result, a concentration-dependent increase in superoxide anion was observed when NC-6300 was irradiated by TP-HIFU. The TP-HIFU irradiation to NC-6300 without WST-1, the superoxide indicator reagent, showed no absorbance change. The amount of superoxide reached a maximum level within 1 min of irradiation under this experimental condition. Moreover, N-6300 showed a superior ability to generate superoxide anion than did EPI. Addition of superoxide dismutase suppressed the absorbance change after TP-HIFU irradiation. The generated amount of superoxide anion was estimated to be in the μM range compared with the concentration of xanthine in the xanthine/xanthine oxidase reaction ([Figure 4](#F4){ref-type="fig"}).

![Measurement of the amount of superoxide anions by UV spectrophotometer. The sample solution containing 0.2 mM WST-1 and the indicated concentration of NC-6300 or EPI (as EPI concentration) was irradiated by TP-HIFU. **(A)** TP-HIFU irradiation to NC-6300 in various concentration and at different irradiation times. **(B)** Correlation with xanthine concentration in xanthine/xanthine oxidase reaction and absorbance change at 438 nm. **(C)** Comparison of the generation of superoxide anion with NC-6300 and EPI. Superoxide dismutase (SOD) was added to confirm generation of the superoxide anion. The absorbance change was measured at 438 nm and that of non-irradiated sample was subtracted. The irradiation groups were collected as three samples and presented as the mean ± standard deviation. ^∗∗^*P* \< 0.01, comparison for each pair by Tukey--Kramer test.](fphar-10-00546-g004){#F4}

To investigate the extracellular function of ROS at the estimated level after TP-HIFU irradiation, we monitored the apoptosis-related changes in the cells using flow cytometry. HL-60 cells were incubated following addition of hydroxyl radicals or superoxide anions using the Fenton reaction or xanthine/xanthine oxidase reaction with or without NC-6300. After 6 h of incubation, FITC- and PI-positive cells were increased after adding both hydroxyl radicals and superoxide anions. This change was accelerated by adding NC-6300 (5 μM), which was not observed after adding NC-6300 alone ([Figure 5](#F5){ref-type="fig"}).

![Flow cytometry analysis of HL-60 cells. The cell suspension was dispensed into test tubes and hydroxyl radicals (HR) or superoxide anions (SA) were added by Fenton reaction or xanthine/xanthine oxidase reaction. After 6-h incubation at 37°C, the samples were measured by flow cytometry. **(A)** FITC and PI intensity changes were monitored to confirm changes in the cell membrane upon extracellular addition of ROS and NC-6300. **(B)** Percentage of the number of FITC- and PI-double-positive cells (Q2 region). Three samples were collected form each group and the results are presented as the mean ± standard deviation. ^∗∗^*P* \< 0.01, comparison for each pair by Tukey--Kramer test.](fphar-10-00546-g005){#F5}

Discussion
==========

To investigate the mechanism of the antitumor effects of NC-6300 and TP-HIFU demonstrated previously ([@B19]), we evaluated the function of TP-HIFU. We found that hydroxyl radical generation was promoted by TP-HIFU irradiation ([Figure 2A](#F2){ref-type="fig"}). We assume that the increase in cavitation bubbles by TP-HIFU increases the production of hydroxyl radicals after sonolysis ([@B21]). It has been reported that 8--15 μM of hydroxyl radicals were generated by sonolysis under the irradiation conditions of 30 W, 1,650 kHz, and 30 and 60 s ([@B24]). In contrast, the output energy of TP-HIFU ([Figure 2A](#F2){ref-type="fig"}) was one-third (10 W) that in the aforementioned study and the same level of hydroxyl radicals were obtained. The amount of hydroxyl radicals increased with increasing irradiation intensity, even with short-duration irradiation, suggesting that higher hydroxyl radical generation occurs when the HIFU intensity is increased. These results indicate that TP-HIFU irradiation produces more hydroxyl radicals in a short duration and the amount of ROS will be \>20 μM under clinical conditions.

Additionally, higher cytoreductivity was observed with the application of TR-HIFU irradiation ([Figure 2B](#F2){ref-type="fig"}). Although the triggering pulse in TP-HIFU is 2000 kw/cm^2^, the duration is very short (0.02 ms/cycle, duty 0.2%). Thus, the total output energy is nearly the same as that of N-HIFU which produces only a heating wave. In the preliminary experiment, the temperature of the microplate well was not increased beyond 35°C throughout irradiation and was within the non-thermal level. Despite these conditions, the difference between TP-HIFU and N-HIFU was clearly noticeable. To clarify the involvement of hydroxyl radicals in cytotoxicity, we carried out an additional experiment with 1 W (10 W/cm^2^) of TP-HIFU irradiation and a hydroxyl radical scavenger. We confirmed cytotoxicity at 1 W, and the effect was suppressed after addition of 2 mM mannitol or histidine ([Supplementary Figure S1](#SM1){ref-type="supplementary-material"}).

The results of EPI degradation by strong TP-HIFU irradiation and similar results obtained from Fenton reaction suggest that EPI degradation by TP-HIFU occurred mainly because of hydroxyl radicals. In contrast, NC-6300 suppressed the degradation of EPI ([Figure 3](#F3){ref-type="fig"}). This may be because EPI localization at the inner core and surrounding hydrophilic moiety created by the PEG-polyamino acid polymer blocked hydroxyl radical attack EPI ([Figure 6](#F6){ref-type="fig"}). It is unclear whether other drugs are protected in a similar manner, and further experiments are necessary.

![Scheme of the characteristic function of NC-6300 in SDT. **(A)** Protective effect from hydroxyl radical. **(B)** Promoting effect of superoxide anion.](fphar-10-00546-g006){#F6}

EPI was not released from NC-6300 even at high-power irradiation (data not shown). The results indicate that the hydrazone bond which conjugates the EPI and polymer was not cleaved by TP-HIFU irradiation even at a high energy. No significant change was observed in the particle size in the nanoparticles after HIFU irradiation (data not shown). These results indicate that cavitation generated under the current conditions cannot cleave the conjugates.

In contrast, the generation of superoxide anions increased following addition of NC-6300 ([Figure 4](#F4){ref-type="fig"}). Although EPI itself functioned as a sonosensitizer for generating superoxide anion, NC-6300 generated more superoxide anion than EPI. We assumed that EPI localized in the inner core at high concentration acted promptly in the ROS generation process ([Figure 6](#F6){ref-type="fig"}). However, the fundamental mechanism underlying the generation of superoxide radicals from epirubicin is unclear and warrants further study ([Figure 6](#F6){ref-type="fig"}).

Reactive oxygen species function is thought to be the key component of SDT. In this study, we estimated the levels of hydroxyl radicals and superoxide anions at the laboratory scale. Hydroxyl radicals are thought to reach up to 20 μM and superoxide anions are estimated to be present at up to one tenth of the hydroxyl radicals. The results of flow cytometry suggested that the cells were susceptible to ROS and that apoptosis-like changes occurred at the outer membrane at 20 μM of hydroxyl radicals and super oxide anions. The hypothesis that ROS might attack from the extracellular matrix is one of the possible causes of this combination treatment. NC-6300 is moved from blood vessel to tumor region by EPR effect and may be first accumulated in the extracellular matrix ([@B5]). We assume that some intervention of ROS could occur from extracellular matrix to membrane ([Supplementary Figure S3](#SM1){ref-type="supplementary-material"}). Further studies are necessary to determine the following mechanism after the ROS have attacked from outside of the cellular membrane.

Furthermore, intracellular ROS levels were not determined in this study. Temporal increases in intracellular ROS levels were observed after 30 min of ultrasound irradiation to metal-porphyrin complexes ([@B10]), despite the short (\<1 s) lifetime of ROS. Combined use of folate-polyethylene-glycol decorated gold nanoparticles and ultrasound irradiation shows remarkable cytotoxicity and ROS production in folate receptor overexpressing cells. However, the effect was suppressed when the cell uptake of the particles was blocked by co-incubation with excess free folate ([@B3]). It is also reported that ROS generated by SDT is related to autophagy ([@B18]; [@B15]). These findings indicates the possibility of a late-phase effect of ROS after TP-HIFU irradiation, warranting further experiments.

In addition, we assume that more therapeutic effects are expected in this therapy because we confirmed cooperative HIFU-derived features (ablation, mechanical destruction, and cavitation), an anticancer drug, and ROS within the dose that is clinically safe. First, cell destruction by TP-HIFU was immediately observed ([Supplementary Figure S2](#SM1){ref-type="supplementary-material"}, 24 h). Second, the anticancer drug suppressed cell proliferation to inhibit tumor growth. Finally, induced apoptosis further decreased the cancer cell population ([Supplementary Figure S2](#SM1){ref-type="supplementary-material"}, 72 h). One possible clinical benefit is that the anticancer drug is no longer necessary for cell reduction because HIFU takes over this function and reduces the dose of drug required from the levels used for cell killing to that for suppressing cell "growth". Thus, the safety margin for drug administration should be reevaluated. Chemo-radio therapy is the most widely used therapy. However, the mechanism of radiotherapy does not provide an immediate effect for physical reduction (such as in surgery and thermal coagulation).

One of the benefits of using drug delivery system carrier conjugation with anticancer drugs is improved safety, which leads to improved quality of life. However, additional non-clinical data are required for each target organ to determine their suitability for treatment with nano-micelles. In some cases, the drug alone be the best treatment. TP-HIFU irradiation may enhance the accumulation of micelles in cancer tissues, which requires further analysis. Moreover, a diagnostic technology that can precisely detect smaller target cancer colonies is required.

It has been reported that various types of cancer-associated cells are localized in the tumor microenvironment ([@B14]). It is thought that there is a specific condition for each cancer-associated cell according to its differentiation and localization. For example, metastatic cells which are about to separate from the primary tumor mass and migrate to another location might form small aggregates or single cells. In contrast, cancer-associated fibroblasts may be in the form of clumps and attached to the tumor ([@B12]), suggesting that ablation is the most efficient form of irradiation. To cover such various microenvironments, combinations of different effects such as the treatment described in this study are thought to be useful ([Supplementary Figure S4](#SM1){ref-type="supplementary-material"}).

In conclusion, drug-conjugated nano-micelles are more desirable for SDT because of accelerated ROS production and drug protection from ROS. Combinatorial treatment with NC-6300 and TP-HIFU is a useful approach for minimally invasive cancer therapy, combining the cooperative effects of HIFU-derived features, anticancer activity of EPI, and increased ROS generation to damage cancer cells.
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